Humana Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Humana Inc trades at $449.75 (market cap $46.49B), while GraniteShares 2x Long NVDA Daily ETF trades at $37.7 (market cap $3.56B). The key difference: Humana Inc is far larger — about 13.1× GraniteShares 2x Long NVDA Daily ETF's market cap, and Humana Inc pays a 0.91% dividend while GraniteShares 2x Long NVDA Daily ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and GraniteShares 2x Long NVDA Daily ETF for 15 Days on average.
| HUM | NVDL | |
|---|---|---|
Market Cap | $46.49B | $3.56B |
Volume | 2,567,704 | 9,740,643 |
Sector | Health | Leveraged / Inverse |
52-Week High | $409.85 | $43.02 |
52-Week Low | $163.67 | $21.76 |
Typical Hold Time | 53 Days | 15 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $39.57, down 1.49% amid mixed technical signals. While moving averages show strong bullish momentum with 13 buy signals, oscillators remain neutral and short-term RSI readings suggest overbought conditions near 75. The ETF tracks Nvidia's performance with 2x daily leverage, benefiting from Nvidia's continued AI leadership and recent earnings beats, though it has underperformed the underlying stock over the past year with 17.21% gains versus NVDA's 22.21%.
The outlook remains cautiously optimistic given Nvidia's dominant AI position and technical breakout potential, but leveraged ETF structure introduces volatility decay risks. Key resistance sits at $41 with support at $39. Investors face concentration risk in the single-stock ETF approach while benefiting from Nvidia's $6 trillion market cap target narrative and strong institutional interest in AI infrastructure plays.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →